LNSR
Price:
$7.38
Market Cap:
$85.72M
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.[Read more]
Industry
Medical - Devices
IPO Date
2020-10-02
Stock Exchange
NASDAQ
Ticker
LNSR
According to LENSAR, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.49%. This represents a change of 297.01% compared to the average of -10.96% of the last 4 quarters.
The mean historical ROE of LENSAR, Inc. over the last ten years is -4.73%. The current -43.49% ROE has changed 819.72% with respect to the historical average. Over the past ten years (40 quarters), LNSR's ROE was at its highest in in the March 2019 quarter at 15.57%. The ROE was at its lowest in in the June 2023 quarter at -26.78%.
Average
-4.73%
Median
-31.00%
Minimum
-46.81%
Maximum
61.53%
Discovering the peaks and valleys of LENSAR, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.71%
Maximum Annual ROE = 61.53%
Minimum Annual Increase = -157.60%
Minimum Annual ROE = -46.81%
Year | ROE | Change |
---|---|---|
2023 | -30.49% | -34.86% |
2022 | -46.81% | 30.71% |
2021 | -35.81% | 13.62% |
2020 | -31.52% | -157.60% |
2019 | 54.71% | -11.09% |
The current ROE of LENSAR, Inc. (LNSR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-37.70%
5-year avg
-17.98%
10-year avg
-4.73%
LENSAR, Inc.’s ROE is greater than RxSight, Inc. (-14.00%), greater than AxoGen, Inc. (-14.91%), greater than Treace Medical Concepts, Inc. (-51.12%), greater than Pulmonx Corporation (-53.88%), greater than Orthofix Medical Inc. (-21.25%), less than Aziyo Biologics, Inc. (78.94%), greater than Ainos, Inc. (-75.16%), greater than Surmodics, Inc. (-9.56%), greater than IRIDEX Corporation (-192.95%), greater than STRATA Skin Sciences, Inc. (-91.63%), less than Sientra, Inc. (95.70%), less than Sight Sciences, Inc. (0%), greater than Dynatronics Corporation (-47.28%), greater than NeuroPace, Inc. (-21.32%), greater than null (-205.41%),
Company | ROE | Market cap |
---|---|---|
-14.00% | $1.81B | |
-14.91% | $587.07M | |
-51.12% | $487.79M | |
-53.88% | $268.12M | |
-21.25% | $722.63M | |
78.94% | $24.21M | |
-75.16% | $6.45M | |
-9.56% | $561.12M | |
-192.95% | $29.95M | |
-91.63% | $12.72M | |
95.70% | $2.08M | |
0% | $203.53M | |
-47.28% | $943.95K | |
-21.32% | $289.53M | |
-205.41% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LENSAR, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LENSAR, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is LENSAR, Inc.'s ROE?
How is the ROE calculated for LENSAR, Inc. (LNSR)?
What is the highest ROE for LENSAR, Inc. (LNSR)?
What is the 3-year average ROE for LENSAR, Inc. (LNSR)?
What is the 5-year average ROE for LENSAR, Inc. (LNSR)?
How does the current ROE for LENSAR, Inc. (LNSR) compare to its historical average?